热门资讯> 正文
InMed收到纳斯达克退市通知
2024-09-21 04:35
- InMed Pharmaceuticals (NASDAQ:INM) has timely requested a hearing before the Nasdaq Listing Qualifications Panel to appeal the determination by Nasdaq, and present its plan to regain and sustain compliance.
- Nasdaq has notified the company via electronic mail that the Hearing has been scheduled for October 31, 2024.
- Source: Press Release
More on InMed Pharmaceuticals
- Financial information for InMed Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。